Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
diabetes
2
×
indiana blog main
investing
life sciences
national blog main
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
seattle blog main
type 1 diabetes
venture capital
2
×
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
aridis pharmaceuticals
aristea therapeutics
arrowmark partners
autoimmune diseases
axitinib
bellus health
beta bionics
bigfoot biomedical
biotech ipos
bolt biotherapeutics
boston
boston university
boulder/denver blog main
boulder/denver top stories
What
patients
2
×
advantages
bar
beta
bio
bionics
blood
brings
closed
developing
device
diabetes
driven
drug
expect
gamble
heads
key
levels
manages
market
medco’s
medical
million
monitors
mover
new
pancreas
payers
physicians
plan
pricing
roundup
secures
sets
startup
sugar
tests
type
ubiome
Language
unset
Current search:
diabetes
×
patients
×
" venture capital "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests